BioNexus Gene Lab Corp. (BGLC)
NASDAQ: BGLC
· Real-Time Price · USD
5.28
-0.08 (-1.49%)
At close: Aug 15, 2025, 3:05 PM
BioNexus Gene Lab Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -1.7 | -3.61 | -1.49 | 10.43 | -26.82 | 7.61 | -1.4 | -36.99 | -339.56 | -262.84 | -592.49 | -353.99 | 4.29K | 1.02K | 171.15 | 1.74K | 265.47 |
PEG Ratio | -0.02 | 0.05 | 0.00 | -0.04 | 0.20 | -0.07 | -0.00 | -0.14 | 6.11 | -2.63 | 13.37 | 0.39 | -53.01 | -14.69 | 0.18 | -19.04 | -1.22 |
PS Ratio | 1.98 | 1.99 | 3.04 | 4.21 | 4.67 | 4.12 | 5.71 | 14.95 | 39.46 | 58.12 | 71.23 | 79.01 | 96.71 | 112.42 | 56.54 | 63.72 | 104.29 |
PB Ratio | 0.55 | 0.60 | 0.85 | 0.87 | 1.19 | 0.97 | 1.51 | 6.43 | 14.31 | 24.76 | 28.56 | 28.78 | 41.09 | 50.81 | 28.67 | 28.92 | 52.96 |
P/FCF Ratio | -5.15 | -68.18 | -4.82 | -12.54 | -221.94 | -35.62 | -14.12 | -1.05K | -804.39 | 360.77 | 604.41 | -976.59 | -4.18K | 757.35 | 584.95 | -210.52 | 3.14K |
P/OCF Ratio | -5.15 | -72.11 | -5.48 | -12.38 | -394.61 | -35.75 | -16.23 | -1.74K | -805.09 | 347.83 | 597.21 | -982.91 | -7.74K | 755.35 | 584.26 | -210.67 | 3.12K |
OCF/S Ratio | -0.39 | -0.03 | -0.55 | -0.34 | -0.01 | -0.12 | -0.35 | -0.01 | -0.05 | 0.17 | 0.12 | -0.08 | -0.01 | 0.15 | 0.10 | -0.3 | 0.03 |
Debt / Equity Ratio | 0.03 | 0.03 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 |
Quick Ratio | 3.44 | 3.10 | 3.99 | 4.87 | 3.98 | 4.24 | 4.36 | 2.16 | 2.92 | 2.52 | 3.23 | 2.83 | 2.50 | 2.42 | 2.22 | 2.09 | 2.01 |
Current Ratio | 4.19 | 3.81 | 4.98 | 5.60 | 4.61 | 4.93 | 5.03 | 2.79 | 3.49 | 3.00 | 4.05 | 3.84 | 3.33 | 3.07 | 2.78 | 2.76 | 2.49 |
Asset Turnover | 0.23 | 0.24 | 0.24 | 0.18 | 0.21 | 0.20 | 0.22 | 0.32 | 0.29 | 0.32 | 0.33 | 0.30 | 0.33 | 0.34 | 0.37 | 0.33 | 0.35 |
Interest Coverage | -125.98 | -71.61 | -215.99 | 57.85 | -60.26 | 61.37 | -593.69 | -89.48 | -20.71 | -25.76 | -31.47 | -59.49 | 10.43 | 50.44 | 173.32 | 40.60 | 101.88 |
Return on Equity | -0.08 | -0.04 | -0.14 | 0.02 | -0.01 | 0.03 | -0.27 | -0.04 | -0.01 | -0.02 | -0.01 | -0.02 | n/a | 0.01 | 0.04 | n/a | 0.05 |
Return on Assets | -0.07 | -0.03 | -0.12 | 0.02 | -0.01 | 0.03 | -0.23 | -0.03 | -0.01 | -0.02 | -0.01 | -0.02 | n/a | 0.01 | 0.03 | n/a | 0.03 |
Return on Invested Capital | -0.08 | -0.04 | -0.14 | 0.02 | -0.04 | 0.03 | -0.26 | -0.04 | -0.01 | -0.02 | -0.01 | -0.02 | n/a | 0.01 | 0.04 | n/a | 0.05 |
Dividend Yield | 0.00 | 0.01 | n/a | n/a | 0.00 | 0.01 | n/a | n/a | n/a | 0.00 | n/a | n/a | n/a | 0.00 | 0.00 | n/a | 0.00 |
Payout Ratio | -0.01 | -0.17 | n/a | n/a | -0.09 | 0.20 | n/a | n/a | n/a | -0.61 | n/a | n/a | n/a | 0.10 | 0.05 | n/a | 0.00 |
Gross Profit Margin | 0.16 | 0.12 | 0.12 | 0.15 | 0.14 | 0.12 | 0.14 | 0.13 | 0.16 | 0.12 | 0.12 | 0.10 | 0.11 | 0.14 | 0.19 | 0.15 | 0.17 |
Net Profit Margin | -0.29 | -0.14 | -0.51 | 0.10 | -0.04 | 0.14 | -1.02 | -0.1 | -0.03 | -0.06 | -0.03 | -0.06 | 0.01 | 0.03 | 0.08 | 0.01 | 0.10 |
Pretax Profit Margin | -0.29 | -0.17 | -0.51 | 0.13 | -0.04 | 0.11 | -0.99 | -0.11 | -0.02 | -0.04 | -0.03 | -0.06 | 0.01 | 0.06 | 0.10 | 0.04 | 0.10 |
Operating Profit Margin | -0.29 | -0.16 | -0.51 | 0.13 | -0.12 | 0.11 | -0.99 | -0.11 | -0.02 | -0.04 | -0.03 | -0.06 | 0.01 | 0.06 | 0.10 | 0.05 | 0.10 |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | -0.29 | -0.15 | -0.49 | 0.15 | -0.02 | 0.13 | -0.98 | -0.1 | -0.01 | -0.03 | -0.02 | -0.04 | 0.02 | 0.07 | 0.11 | 0.06 | 0.10 |